Preferred Securities out of Shareholders Equity (Quarterly) Chart

View Preferred Securities out of Shareholders Equity (Quarterly) for LENZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Securities out of Shareholders Equity (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. --
Liminatus Pharma, Inc. --
Oruka Therapeutics, Inc. --
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. --